Fludarabine phosphate in the treatment of chronic lymphocytic leukemia: Biology, clinical impact, and future directions-Reference-Cited by-同舟云学术

Fludarabine phosphate in the treatment of chronic lymphocytic leukemia: Biology, clinical impact, and future directions

Published:1993 Issue: Volume: Page:105-119
ISSN:0927-3042
Container-title:Leukemia: Advances in Research and Treatment
language:
Short-container-title:

Author:

Robertson L. E.,Keating Michael J.

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-4615-3086-2_6.pdf

Reference70 articles.

1. Brink JJ, LePage GA (1964). Metabolic effects of 9-D-arabinosyl purines in ascites tumor cells. Cancer Res 24: 312–318.

2. Montgomery JA, Hewson K (1969). Nucleosides of 2-fluoroadenosine. J Med Chem 12: 498–504.

3. Brockman RW, Cheng Y-C, Schable FM Jr, et al. (1980). Metabolism and chemotherapeutic activity of 9-β-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase. Cancer Res 40: 3610–3615.

4. Montgomery JA (1982). Has the well gone dry? The first Cain Memorial Award lecture. Cancer Res 42: 3911–3917.

5. Leiby JM, Snider KM, Kraut EH, et al. (1987). Phase II trial of 9-β-D-arabinofuranosyl-2-fluoroadenine-5′-monophosphate in non-Hodgkin’s lymphoma: Prospective comparison of response with deoxycytidine kinase activity. Cancer Res 47: 2719–2722.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fludarabine in chronic lymphocytic leukaemia;Expert Opinion on Pharmacotherapy;2006-07-28

2. Prolymphocytic leukemia;Current Treatment Options in Oncology;2005-05

3. 20th‐Century Advances in Drug Therapy in Oncology—Part I;The Journal of Clinical Pharmacology;2000-09

4. Fludarabine phosphate in lymphoma: an important new therapeutic agent;Cancer Treatment and Research;1997

5. New drugs in non-Hodgkin's lymphoma;Annals of Oncology;1997